Injective CEO Eric Chen expects US INJ ETFs to launch in Q4, says 2027 'too far'

Injective CEO Eric Chen expects US spot INJ ETFs to launch in Q4, saying 2027 is "too far," according to The Block. Two INJ ETF filings are pending, from 21Shares and Canary Funds.

Detected & updated continuously · Source: Nebula